Clinical trials
PET clinical trials
Below are recruiting pet clinical trials, each written for real people, not researchers. We’re tracking 592 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06335914Recruiting
Dual PET scans for advanced prostate cancer
This study tests whether two kinds of PET scans, one targeting PSMA and one targeting sugar uptake (FDG), can help doctors better understand advanced prostate cancer. If you have prostate cancer that has spread (metastatic) and still responds to hormone therapy, the scans may help guide your treatment.
Toronto, OntarioAges 18 years+ - NCT06120049RecruitingPhase 2/Phase 3
Comparing new PET scans for Parkinson's, MSA, Lewy body dementia, and Alzheimer's
This study tests if a new radioactive tracer called [18F]-MFBG can help doctors better distinguish between Parkinson's disease, multiple system atrophy (MSA), dementia with Lewy bodies, and Alzheimer's disease. It compares the new scan with two standard scans to see which is most accurate.
Ghent, GentAges 18–85 - NCT05586581RecruitingPhase 1/Phase 2
PET and MRI scans to study brain changes in treated HIV
This study uses PET and MRI scans, plus blood tests and memory/thinking questionnaires, to understand what drives brain problems in people living with HIV even during treatment. It may help researchers learn why symptoms happen and how treatment relates to brain function.
New Haven, ConnecticutAges 18–80 - NCT06457789Recruiting
PET scans to track immune response in lung cancer treatment
This study uses special PET scans to see how well your immune cells respond to immunotherapy given before surgery for non-small cell lung cancer. The goal is to learn which patients benefit most from this treatment approach.
Amsterdam, North HollandAges 18 years+ - NCT05011760RecruitingEarly Phase 1
PET brain scan with a cocaine-use disorder medicine test
This early-phase study uses a PET brain scan (a special imaging test) to see how the brain responds in people with cocaine use disorder. It aims to better understand brain activity and whether this scan approach could help research or future treatments.
Pittsburgh, PennsylvaniaAges 18–55 - NCT07324733Recruiting
PSMA PET scan for Sjögren's syndrome
This study uses a special PET scan called PSMA to look at inflammation in Sjögren's syndrome, comparing the results with another type of PET scan (FAPI). It may help doctors better understand the disease and find new ways to track it.
BeijingAges 18–80 - NCT07147309Recruiting
PET scans for epilepsy surgery planning
This trial tests three types of PET scans to help doctors exactly locate the part of the brain causing seizures before surgery. It's for people with epilepsy that isn't controlled by medication and who are already planning surgery or an SEEG.
Fuzhou, FujianAges 18–50 - NCT04383808Recruiting
PET/MRI scan with a small injected tracer
This study tests a new brain PET “insert” that can work at the same time as MRI to create brain images. If you’re healthy and can receive an approved injected tracer (FDG or Neuraceq), you may be able to help confirm the device works safely and clearly.
Palo Alto, CaliforniaAges 21 years+ - NCT04787744RecruitingPhase 2/Phase 3
Test standard prostate cancer treatment with or without targeted spot radiation
This study tests whether adding targeted local treatment (like radiation to a few spots seen on scans) improves outcomes for some people with limited (oligometastatic) prostate cancer. It compares standard systemic therapy alone versus standard therapy plus PET-scan–guided spot treatment.
Long Beach, CaliforniaAges 18 years+ - NCT04987086Recruiting
68Ga PSMA PET-CT for kidney cancer spread
This study checks whether a special PET-CT scan using 68Ga PSMA can better find where renal cell carcinoma has spread. It may help doctors plan the right next steps by confirming suspected metastases on CT.
Lanzhou, GansuAges 18–90 - NCT05360082Recruiting
Brain scan study comparing two PET tracers in Huntington disease
This study compares two different brain imaging tracers to see which one shows Huntington disease brain changes better. It may help improve how doctors measure and track Huntington disease using PET-MRI scans.
LeuvenAges 20–75 - NCT06358222Recruiting
Lung cancer trial testing blood test and PET scan for spread
This trial studies if a blood test that looks for tumor DNA combined with a PET-CT scan can better predict if lung cancer has spread to lymph nodes. It may help guide treatment decisions for people with non-small cell lung cancer that hasn't been treated yet.
ShanghaiAges 18–75 - NCT07243873Recruiting
Improving lung cancer diagnosis with synthetic PET scans
This study uses a computer-generated PET scan from your CT scan to help doctors diagnose and plan treatment for non-small cell lung cancer more precisely. It is observational, meaning no new treatments are given—just extra imaging analysis.
Zunyi, GuizhouAges 18–85 - NCT02019706RecruitingPhase 2
PET/CT scans to find the cause of ectopic Cushing syndrome
This trial tests several special imaging scans to help doctors locate the source of hormone overproduction in ectopic Cushing syndrome. It may help confirm where the problem is so treatment can be better targeted.
Bethesda, MarylandAges 18–80 - NCT07443696RecruitingPhase 2
Heart imaging test to see if bypass surgery could help
This study uses two imaging scans to see if parts of your heart muscle are still alive but not working well. This could help doctors decide if you might benefit from heart bypass surgery.
Beijing, Beijing MunicipalityAges 18–85 - NCT07471776RecruitingPhase 2
Predicting ADC treatment response with PET scans in advanced breast cancer
This study uses special PET scans to see if a type of targeted therapy called an anti-TROP2 ADC will work well for your advanced breast cancer. The therapy is already part of your standard care; the scans help doctors understand how your tumor responds.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07472049Recruiting
Imaging plaque activity in peripheral artery disease
This trial studies plaque activity in leg arteries using a new imaging method to understand artery disease better. It may help people with peripheral artery disease get more targeted treatment.
Edinburgh, MidlothianAges 18 years+ - NCT07774650RecruitingEarly Phase 1
Imaging study of immune activity in healthy volunteers
This study tests a new imaging agent that may help show immune activity in the body using a PET scan. It is being tested in healthy volunteers to see how it behaves and to help plan future studies.
New Haven, ConnecticutAges 18–60 - NCT07752784RecruitingPhase 3
Tau brain imaging in people with mild thinking changes or Alzheimer's
This study uses a special PET scan to take pictures of abnormal tau protein in the brain. It aims to see if the scan results match what is found in brain tissue after death, which could help improve diagnosis of Alzheimer's and related conditions.
Beijing, Beijing MunicipalityAges 50 years+ - NCT04999215RecruitingPhase 3
Test whether F-choline PET scans help in new conditions
This study checks how useful an F-choline PET scan is for finding information in people with known or suspected conditions. It may help doctors decide what to look for or how to guide care in “new and emerging” situations.
Montreal, QuebecAges 18 years+ - NCT06894745RecruitingPhase 1
PET imaging of solid tumors with 89Zr-DFO-starPEG
This early-phase trial tests a new imaging agent called 89Zr-DFO-starPEG that may help doctors see solid tumors more clearly on PET scans. It is a safety and imaging study, not a treatment, and may help find tumors in people with various types of cancer.
San Francisco, CaliforniaAges 18 years+ - NCT06659705RecruitingPhase 2
New PET scan for early pancreatic cancer detection
This trial tests a new type of PET scan that uses a special tracer (FAPI) to get clearer images of pancreatic cancer. The goal is to find cancer earlier and better plan surgery or treatment.
Saint-CloudAges 18 years+ - NCT06467968Recruiting
Heart analysis during DOTATOC PET/CT for neuroendocrine tumors
This study looks at how a PET/CT scan (called gallium-68 DOTATOC) can also check your heart health while scanning for a neuroendocrine tumor. It aims to see if the routine scan can give extra information about your heart function without any extra visits or radiation.
Vandœuvre-lès-NancyAges 18 years+ - NCT05400967RecruitingEarly Phase 1
Scan metastatic tumors and test targeted radiation treatment
This trial looks at whether a special PET scan can find metastatic tumors and guide a targeted radiation treatment. It may help people by improving how doctors locate tumors and decide where to deliver therapy.
Beijing, Beijing MunicipalityAges 18–80
Hear when a new PET trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pet?
- Yes. Clin2 currently lists 592 recruiting pet studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pet trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pet trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.